4//SEC Filing
Chanda Sanjay 4
Accession 0000899243-23-005557
CIK 0001880438other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 7:28 PM ET
Size
5.4 KB
Accession
0000899243-23-005557
Insider Transaction Report
Form 4
Chanda Sanjay
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-15+57,950→ 57,950 totalExercise: $14.29Exp: 2033-02-14→ Common Stock (57,950 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest as follows: 1/48 of the shares shall vest on each monthly anniversary as measured from January 1, 2023.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001571820
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 7:28 PM ET
- Size
- 5.4 KB